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Fusion proteinCytochrome bc1 complex catalyzes the reaction of electron transfer from ubiquinol to cytochrome c (or cyto-
chrome c2) and couples this reaction to proton translocation across the membrane. Crystallization of the Rho-
dobacter sphaeroides bc1 complex resulted in crystals containing only three core subunits. To mitigate the
problem of subunit IV being dissociated from the three-subunit core complex during crystallization, we re-
cently engineered an R. sphaeroides mutant in which the N-terminus of subunit IV was fused to the C-
terminus of cytochrome c1 with a 14-glycine linker between the two fusing subunits, and a 6-histidine tag
at the C-terminus of subunit IV (c1-14Gly-IV-6His). The puriﬁed fusion mutant complex shows higher elec-
tron transfer activity, more structural stability, and less superoxide generation as compared to the wild-
type enzyme. Preliminary crystallization attempts with this mutant complex yielded crystals containing
four subunits and diffracting X-rays to 5.5 Å resolution.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The cytochrome bc1 complex from the photosynthetic bacterium
Rhodobacter sphaeroides catalyzes electron transfer from ubiquinol
to cytochrome c2 in a cyclic photosynthetic electron transfer chain
[1,2]. Oxidation of ubiquinol is coupled to the translocation of protons
across the membrane to generate a pH gradient and membrane po-
tential that are used for ATP synthesis. This bacterial complex con-
tains four protein subunits with apparent molecular masses of 43,
31, 23 and 14 kDa. The three larger subunits are: cytochrome b, hav-
ing two b-type hemes (b562 and b566), cytochrome c1, containing one
c-type heme (c1) and the iron–sulfur protein (ISP), including a [2Fe–
2S] cluster [1,3]. These three subunits are present in all the cyto-
chrome bc1 complexes and are thus termed the core subunits. The
smallest subunit contains no redox prosthetic group and is a supernu-
merary subunit [4,5]. While the study of the core subunits has been
intensive and has produced a wealth of information, the study of su-
pernumerary subunits has been rather limited. The presence of only
one supernumerary subunit (subunit IV) in the R. sphaeroides com-
plex provides us with an ideal system for the structural and functional
study of the supernumerary subunit., 2,3-dimethoxy-5- methyl-6-
ltoside; OG, n-octyl-beta-D-
methyl-(10-bromodecyl)1,4-
l)-3,7-dihydroimidazo[1,2-α]
+1 405 744 7799.
l rights reserved.The gene for subunit IV (fbcQ) of R. sphaeroides bc1 complex has
been cloned and sequenced [6]. A mutant that lacks subunit IV
(RSΔIV) has been constructed [7]. The cytochrome bc1 complex puri-
ﬁed from RSΔIV chromatophores contains only the three core sub-
units and has only a fraction of the wild-type complex activity [7].
Subunit IV has been over-expressed in Escherichia coli cells as a GST
fusion protein and puriﬁed to homogeneity with a procedure involv-
ing glutathione agarose gel, thrombin digestion, and gel ﬁltration [8].
When puriﬁed recombinant subunit IV was added to the three-
subunit core complex, the bc1 activity was restored to the level of
the wild-type complex, indicating that recombinant subunit IV can
properly assemble into the cytochrome bc1 complex [8]. The availabil-
ity of reconstitutively active, three-subunit core complex and recom-
binant subunit IV enables us to use an in vitro reconstitution approach
to identify the amino acid residues of subunit IV involved in interac-
tion with the core complex [9,10]. Residues 81–84, with a sequence
of YRYR [10], and residues 86–109, which comprise the only trans-
membrane helix in subunit IV [9], are essential. It has been suggested
that subunit IV is incorporated into the bc1 complex through its trans-
membrane helix and then interacts with the core subunits through
residues 81–84 to restore the bc1 activity to the level of the wild-
type complex [10]. However, it is not known how this interaction
can restore the bc1 activity.
Recently, we have observed several interesting results [11], in-
cluding (i) in the three-subunit core complex, the extent of cyto-
chrome b reduction by ubiquinol in the presence of antimycin A
cannot reach the same level as that in the wild-type complex; (ii)
the core complex produces 4 times more superoxide than the wild-
type complex; and (iii) the activity of reconstituted complexes,
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Scheme 1. Strategy for the construction of the c1-6Gly-IV-6His mutant.
Table 1
The oligonucleotides used for mutations.
c1-6Gly(F) 5′ CTAG TCT AGA AGG GAA AGG ACA GTG 3′
c1-6Gly(R) 5′ GCC ACC GCC ACC GCC ACC GAC GTT CGT CTT CTT CTT GCC 3′
6Gly-IV-
6His(F)
5′ GGT GGC GGT GGC GGT GGC ATG TTC TCA TTC ATC GAC GAC3′
6Gly-IV-
6His(R)
5′ CCG CTC GAG TTA GTG ATG GTG GTG GTG ATG TTC GAT GGG
ATA GAC GAC GCT 3′
c1-10Gly(R) 5′ GCC ACC GCC ACC GCC ACC GCC ACC GCC ACC GAC GTT CGT CTT
CTT CTT GCC 3′
10Gly-IV-
6His (F)
5′ GGT GGC GGT GGC GGT GGC GGT GGC GGT GGC ATG TTC TCA
TTC ATC GAC GAC 3′
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tional to its superoxide production activity. Although these ﬁndings
may suggest that subunit IV increases the bc1 complex activity [11]
by preventing electron leakage from the low potential electron trans-
fer chain and thereby keeping electrons from reacting with molecular
oxygen to produce superoxide anions [12–15], the mechanism
through which subunit IV performs these functions is yet to be
elucidated.
Apparently, crystallization of R. sphaeroides cytochrome bc1 com-
plex and subsequent three-dimensional structure analysis of this
complex will provide invaluable information to our understanding
of the function of subunit IV in the cytochrome bc1 complex. Unfortu-
nately, crystallization of the R. sphaeroides wild-type, four-subunit
complex resulted in crystals containing only the three core subunits
[16]. Apparently subunit IV was dissociated from the core complex
during crystallization. Although crystals of this three-subunit core
complex diffracted X-rays to 2.1 Å resolution [16], the lack of subunit
IV limited the utility of this bacterial structure. One way to obtain a 3-
D structure of the four-subunit complex is to covalently link subunit
IV to one of the core subunits, thereby preventing the dissociation
of subunit IV from the complex during crystallization. This approach
is feasible only if the generated fusion mutant complex has similar
or even better characteristics as compared to that of the wild type,
four-subunit complex.
Here, we report procedures for generating R. sphaeroides mutants
expressing His6-tagged bc1 complex with the N-terminus of subunit
IV fused to the C-terminus of cytochrome c1. Photosynthetic growth
behavior, enzymatic activity, structural stability, and superoxide pro-
duction of fusion mutant complexes with a polyglycine linker of two
different lengths were examined and compared with the wild-type
complex. Crystals of one such fusion mutant have also been obtained,
diffracting X-rays to 5.5 Å resolution.
2. Materials and methods
Cytochrome c, (horse heart, type III), Ni-NTA gel, and QiAprep
Spin Miniprep Kit were purchased from Sigma. N-dodecyl-ß-D-Mal-
topyranoside (DM) and N-octyl-ß-D-Glucopyranoside (OG) were
purchased from Anatrace. Stigmatellin was purchased from Fluka.
2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-α]pyrazin-
3-one, hydrochloride (MCLA) was purchased from Molecular
Probes, Inc. 2,3-Dimethoxy-5-methyl-6-(10-bromodecyl)-1,4-benzo-
quinol (Q0C10BrH2) was prepared in our laboratory as previously
reported [17]. All other chemicals were of the highest purity commer-
cially available.
2.1. Growth of bacteria
E. coli cells were grown at 37 °C in LB medium. An enriched Sis-
tröm medium containing 5 mM glutamate and 0.2% casamino acids
was used for photosynthetic growth of the plasmid-bearing R. sphaer-
oides cells [18]. The conditions for photosynthetic growth were simi-
lar to what has been described previously [19]. Antibiotics were
added to growth media at the following concentrations: tetracycline,
10–15 mg/L, and trimethoprim, 25 mg/L for E. coli; tetracycline, 1 mg/L,
kanamycin sulfate, 20 mg/L, and trimethoprim, 25 mg/L for R.
sphaeroides.
2.2. Generation of R. sphaeroides mutants expressing His-tagged bc1
complex with the N-terminus of subunit IV fused to the C-terminus of cy-
tochrome c1
Two mutants with the N-terminus of subunit IV fused to the C-
terminus of cytochrome c1 were constructed: one with a 6-glycine
linker placed between the two fusing subunits and a 6-His tag at
the C-terminus of subunit IV (c1-6Gly-IV-6His); the other with a 14-glycine linker between the two fusing subunits and a 6-His tag at
the C-terminus of subunit IV (c1-14Gly-IV-6His). Scheme 1 outlines
the strategy used for construction of c1-6Gly-IV-6His. The construc-
tion was divided into three parts. The aim of part I was to generate
an XbaI–XhoI DNA fragment encoding c1-6Gly-IV-6His. This was
achieved by three PCR ampliﬁcation reactions: the ﬁrst one was to
generate a DNA fragment encoding c1-6Gly (fragment A); the second
one was to produce a DNA fragment encoding 6Gly-IV-6His (frag-
ment B) and the third one was to generate a DNA fragment encoding
c1-6Gly-IV-6His (fragment C). The ﬁrst two PCR reactions used the
pRKDfbcFBC6HQ[19] as template, and the third PCR ampliﬁcation reac-
tion used a mixture of fragments A and B as templates. The forward
and reverse primers used (see Table 1) were: c1-6Gly(F) and c1-
6Gly(R) for the ﬁrst PCR ampliﬁcation; 6Gly-IV-6His (F) and 6Gly-
IV-6His(R) for the second; and c1-6Gly(F) and 6Gly-IV-6His(R) for
the third. The produced DNA fragment C was digested with XbaI
and XhoI to generate an XbaI–XhoI fragment encoding c1-6Gly-IV-
6His. The goal of part II was to ligate the XbaI–XhoI fragment into
the XbaI and XhoI digested pRKDfbcFBC6HQ plasmid and then trans-
form the resulting plasmid, pRKDfbcFBC6GQ6H, into E. coli S17 cells.
In part III, we transferred pRKDfbcFBC6GQ6H from E. coli S17 cells to
R. sphaeroides BC17 cells by plate conjugation according to previously
reported procedures [18–20].
The c1-14Gly-IV-6His mutant was constructed by the same proto-
col used for construction of mutant c1-6Gly-IV-6His except that the
reverse primer used in generation of fragment A was c1-10Gly(R)
and the forward primer for fragment B was 10Gly-IV-6His (F) (see
Table 1). It should be noted that when the generated fragments A
and B (each encoding 10 glycines) were used as templates for gener-
ating fragment C at the annealing temperature of 56 °C, only DNA
encoding 6 glycines from each fragment was paired, resulting in 14
glycines between cytochrome c1 and subunit IV.
2.3. Puriﬁcation of mutant complexes and the activity assay
Chromatophore membranes were prepared from wild-type and
mutant cells. The cytochrome bc1 complexes were puriﬁed from chro-
matophores as described previously [20] and stored at −80 °C con-
taining 10% glycerol until use. The concentrations of cytochromes b
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using published molar extinction coefﬁcients.
To assay the activity of ubiquinol–cytochrome c reductase, chro-
matophores or puriﬁed cytochrome bc1 complexes were diluted
with 50 mM Tris–HCl buffer, pH 8.0, containing 200 mM NaCl and
0.01% DM to a ﬁnal concentration of cytochrome b of 1 μM. Appropri-
ate amounts of the diluted proteins were added to 1 mL of assay mix-
ture containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM
EDTA, 50 μM cytochrome c, and 25 μM Q0C10BrH2. The reduction of
cytochrome c was measured by the increase of the absorbance at
550 nm wavelength in a Shimadzu UV-2401 PC spectrophotometer
at 23 °C. A millimolar extinction coefﬁcient of 18.5 [22] was used for
calculation of the activity. The non-enzymatic oxidation of
Q0C10BrH2, before the addition of enzyme, was subtracted in the cal-
culation of speciﬁc activity. Q0C10BrH2 is a better substrate than
Q0C10H2 for the cytochrome bc1 complex [17].
2.4. Gel electrophoresis and Western blot
The SDS-PAGE was performed with a Bio-Rad Mini-Protein dual
slab vertical cell. Samples were treated with a sample buffer contain-
ing 10 mM Tris–HCl buffer, pH 6.8, 1% SDS, 3% glycerol and 0.4% β-
mercaptoethanol (β-ME) for 10 min at room temperature before
electrophoresis. The polypeptides on SDS-PAGE gel were transferred
to 45 μm nitrocellulose membrane and probed with antibodies
against subunit IV or against cytochrome c1 of the R. sphaeroides bc1
complex. Horseradish peroxidase (HRP) conjugated protein A was
used as secondary antibody. HRP color development solution (Bio-
Rad) was used to detect the protein bands that speciﬁcally reacted
to the antibodies.
2.5. Enzyme-linked immunosorbent assay (ELISA)
A modiﬁed ELISA [23] was used for quantitative comparison of
subunit IV in the wild-type and c1-14Gly-IV-6His mutant complexes.
The wild-type and mutant complexes were diluted with a carbonate
buffer, pH 9.5, containing 15 mM Na2CO3, 35 mM NaHCO3, and
0.02% NaN3, to a protein concentration of 10 μg/mL. Aliquots of
100 μL of diluted enzyme solutions were added to each well of the
ELISA plate and incubated, overnight, at 4 °C. After incubation, the un-
bound bc1 complex was removed from the well and blocking buffer
(1% casein in PBS buffer containing 137 mM NaCl, 2.7 mM KCl,
8.1 mM Na2HPO4•2H2O, and 1.76 mM KH2PO4, pH 7.4) was added.
After the plate was incubated at 37 °C for 1 h, the blocking buffer
was then removed and the wells were washed with 280 μL of PBS
buffer. An aliquot of 125 μL of 1:500 diluted anti-subunit IV antibody
was added per well and the plate was incubated at room temperature
for 1 h. The wells were then washed 3 times with PBS buffer. The
horseradish peroxidase (HRP)-conjugated Protein A was added as
the second antibody and incubated for another hour. After washing,
binding of the second antibody was detected by applying 100 μL of
tetramethyl benzidine (TMB) substrate. The reaction was stopped
by adding 100 μL of 1 N HCl to each well. The plate was read at
450 nm using a multi-well plate reader.
2.6. Differential scanning calorimetry (DSC) measurement
DSC measurements were performed using Nano-DSC II from Calo-
rimetry Sciences Corp. The sample and reference solutions were
degassed before use. The wild-type and c1-14Gly-IV-6His mutant
complexes were diluted with a degassed buffer containing 100 mM
Na+/K+ phosphate, pH 7.4, and 0.01% DM to a ﬁnal concentration
of 2 mg/mL(36 µM of cytochrome b). The diluted protein solution
was then injected into the sample cell and the control buffer into
the reference cell. The data acquisition DSC program (10–90 °C/3
scans) was run at a rate of 1 °C/min. The cells were equilibrated for10min before the heating and cooling processes. The DscRun program
recorded the input heat ﬂow difference between the sample cell and
reference cell and plotted the data as a function of temperature. The
CpCalc program calculated transition temperature and enthalpy
change of transition using the second heating as a baseline for analysis.
2.7. Quantitative comparisons of the iron–sulfur cluster in the wild-type
and fused mutant complexes by EPR
Aliquots of 300 μL of puriﬁed wild-type and mutant cytochrome
bc1 complexes (cytochrome b=100 μM)were treated with 5-fold ex-
cess of ascorbate to fully reduce cytochrome c1 and frozen in liquid ni-
trogen. EPR spectra were recorded at −150 °C in a Bruker EMX EPR
spectrometer with the following instrument settings: center ﬁeld,
3600 G; microwave frequency, 9.397021 GHz; microwave power
2.16 mW; modulation frequency, 100.00 kHz; modulation amplitude,
6.3 G; time constant, 655.36 ms; conversion time, 163.84 ms; sweep
time, 167.77 s; number of X-scans, 4.
2.8. Determination of superoxide production
The production of superoxide anion by the cytochrome bc1 com-
plex was determined by measuring the chemiluminescence of the
MCLA-O2.− adduct [24] in an Applied Photophysics Stopped-ﬂow Re-
action Analyzer SX.18 MV (Leatherhead, England), while leaving the
excitation light off and registering light emission [25,26]. Reactions
were carried out at 23 °C by mixing solutions I and II in a 1:1 ratio. So-
lution I contained 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM
EDTA, 1 mM KCN/ 1 mM NaN3, 0.1% bovine serum albumin, 0.01%
DM, and wild-type or mutant bc1 complex (4 μM cytochrome b). So-
lution II contained 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM
EDTA, 1 mM KCN/1 mM NaN3, 0.1% bovine serum albumin, 0.01%
DM, 67 μM Q0C10BrH2 and 4 μM MCLA.
2.9. Protein crystallization
The puriﬁed c1-14Gly-IV-6His mutant complex was diluted to a
protein concentration of 12 mg/mL with a buffer containing 50 mM
Tris–HCl, pH 7.5, 200 mM NaCl, 10% glycerol, 5 mM NaN3, 0.5% β-OG
(Anatrace) and 200 mM histidine. The diluted protein solution was
treated with a 5-fold molar excess of stigmatellin at 4 °C for 5 h. An
aliquot of the solution was augmented with 0.06% sucrose monocap-
rate (Fluka), 50 mM potassium nitrate, and 8% PEG 400. The solution
was incubated overnight at 4 °C and centrifuged at 44,000×g to re-
move precipitates, if any. The supernatant was used in sitting drop
crystallization experiments at 15 °C. The reservoir solution contained
100 mM Tris-Cl, pH 8.0, 600 mM NaCl, 20% glycerol, 5 mM NaN3, and
26% PEG 400.
3. Results and discussion
3.1. The rationale for the generation of mutants expressing cytochrome
bc1 complex with the N-terminus of subunit IV fused to the C-terminus
of cytochrome c1
One approach used to prevent subunit IV from dissociating from
the three-subunit core complex during crystallization is to generate
mutants with subunit IV fused into one of the three core subunits (cy-
tochrome b, cytochrome c1 or ISP) of the cytochrome bc1 complex.
Two fusion mutants, c1-6Gly-IV-6His and c1-14Gly-IV-6His, in which
the N-terminus of subunit IV is fused to the C-terminus of cytochrome
c1, with a 6- or 14-glycine linker between the two fusing subunits and
a 6-his tag at the C-terminus of subunit IV, were constructed for this
study.
The decision to fuse the N-terminus of subunit IV to the C-
terminus of cytochrome c1 is based on the following information:
3.0
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brane helix in the subunit; (ii) the study of the topological arrange-
ment of subunit IV in the chromatophore membrane [9] indicates
that the N-terminus of the subunit is located at the cytoplasmic side
of the membrane; (iii) the 3-D structural information of the R. sphaer-
oides three-subunit core complex 2QJY [16] shows that the C-
terminus of cytochrome c1 subunit is on the cytoplasmic side.
The current structural model of subunit IV in the c1-14Gly-IV-6His
mutant complex, as shown in Fig. 1 with the red color, was con-
structed by the following ways: (i). The TMHMM and TMpred pro-
grams [27,28] predict a single transmembrane helix for subunit IV
with nearly 100% probability from residues 87 to 105. (ii). The pre-
dicted helix was aligned with subunit VII from bovine heart mito-
chondrial bc1. Despite the low sequence identity, the C-terminal
ends of subunit IV and beef VII show a sequence pattern that allows
a plausible alignment. (iii). The transmembrane helix of beef subunit
VII is preceded by a horizontally extended helix featuring a number of
polar residues. Similar to that, the putative TM helix of subunit IV is
preceded by a polar helix (by secondary structure prediction) of com-
parable length. (iv). Subunit VII of beef mitochondrial bc1 was used as
a template for subunit IV from residues 64 to 104. (v). Residues 1–63
were modeled by I-Tasser [29] producing only domains with low
scores due to the as of yet unique sequence of subunit IV. The best
of the ﬁve models that I-Tasser produced was combined with the seg-
ment that was modeled using beef subunit VII as template. (vi). It is
directly connected residue 1 of the modeled subunit IV with a 14-
Gly linker (shown in magenta color) to the C-terminus of cytochrome
c1. A 14-Gly linker in the fully extended (beta-strand) form covers a
distance of 14×3.32 Å=46.5 Å, and the N-terminal end of sub IV is
well within the reach of this linker. (vii). The model was then energy
minimized and arranged in a way that is compatible (no clashes) with
the current crystallographic data (cell dimensions and space group).
The topological arrangement of the transmembrane helix in the
proposed structural model of subunit IV was determined previously
using antibodies against synthetic peptides corresponding to the
near N-terminal and the C-terminal peptides, in sealed (inside-out)
and broken chromatophores [9]. Since antibodies against the C-
terminal peptide react only with the broken chromatophores while
antibodies against N-terminal peptide react with both sealed and bro-
ken chromatophores, the N-terminal end of subunit IV is exposed on
the cytoplasmic side and the C-terminal end is on the periplasmic side
of the chromatophore membrane. This topological arrangement study
placed the ﬁrst 85 amino acid residues of subunit IV on the cytoplas-
mic side of the membrane, where more space is available for proper
folding of this large portion of subunit. Since the N-terminus of sub-
unit IV is located on the cytoplasmic side of the membrane, the need
for the generation of fusion mutants with the N-terminus of subunitPeriplasmic side
Cytoplasmic side
Fig. 1. Structural model of subunit IV in the c1-14Gly-IV-6His mutant complex. Subunit
IV is in red, cyt. b in light green, ISP in yellow and cyt. c1 in royal blue. The 14-glycine
linker is in magenta.IV on the periplasmic side of the chromatophore membrane is
eliminated.
In the recently available 3-D structure of the R. sphaeroides three-
subunit core complex [16], the C-terminus of cytochrome c1, and the
N- and C-terminus of cytochrome b are located on the cytoplasmic
side of the membrane. Therefore, by fusing the N-terminus of subunit
IV into the C-termini of either cytochrome c1 or cytochrome b (see
Fig. 1), one should obtain a mutant bc1 complex with correct orienta-
tion of subunit IV, i.e., the N-terminus is located on the cytoplasmic
side of the membrane. Although the cytochrome b subunit also has
its C-terminus at the cytoplasmic side, we decided to fuse the subunit
IV gene to the cytochrome c1 gene instead of the cytochrome b gene,
because the cytochrome b subunit is located at the innermost section
of the complex. It is very likely that a fusion of subunit IV with the C-
terminus of cytochrome b would prevent proper assembly, leading to
interferences in the interactions between cytochromes b and c1 and/
or ISP.
In order to increase the structural ﬂexibility of the fused subunits,
a linker of 6 or 14 glycine residues was introduced between the two
fusing subunits. Glycine was chosen as the linker residue because it
is the smallest amino acid with the greatest ﬂexibility. Introducing
the glycine linker should preserve the structural integrity of the two
fused subunits in the bc1 complex. The length of glycine linker select-
ed was somewhat arbitrary. Although a 14-glycine linker is calculated
to be sufﬁcient to cover the distance from the C-terminus of cyto-
chrome c1 to the N-terminus of subunit IV, it is still possible that a
linker longer than 14 glycine is needed. We chose a 6- and 14-
glycine linker to start this study and with intention to use a longer
glycine linker if these two linkers are proved experimentally not to
be long enough. To facilitate the puriﬁcation of mutant complexes, a
6-histidine tag was introduced at the C-terminus of subunit IV.
3.2. Photosynthetic growth behavior of c1-6Gly-IV-6His and c1-14Gly-IV-
6His mutants
Because a functional bc1 complex is absolutely required for the
photosynthetic growth of R. sphaeroides, the degree to which these
two fusion constructs affect the activity of the complex can be deter-
mined by analyzing their photosynthetic growth behavior. Wild-type
and mutant cells harboring c1-6Gly-IV-6His or c1-14Gly-IV-6His bc1
complexes grown aerobically in mid-log phase were transferred
into Sistrom medium at the same cell density and subjected to anaer-
obic photosynthetic growth conditions (see Fig. 2). The wild-type
cells began exponential growth after a lag phase of 24 h, whereas0 20 40 60 80 100 120 140 180
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Fig. 2. Photosynthetic growth of R. sphaeroides strains. Aliquots of mid-log phase aero-
bically grown wild type (o), c1-14Gly-IV-6His (x) and c1-6Gly-IV-6His (Δ) cells were
inoculated into Sistrom A minimal medium containing 20 μg/mL kanamycin, 25 μg/mL
trimethoprim, and 1 μg/mL tetracycline. Growth was monitored at OD600 nm.
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after a lag of 64 and 120 h, respectively. This indicates that fusion con-
structs caused the delay of photosynthetic growth. The length of
delay for photosynthetic growth increased as the length of glycine
linker in the fusion mutant decreased, suggesting that the lag time
for photosynthetic growth decreased as the structural ﬂexibility be-
tween the N-terminus of subunit IV and the C-terminus of cyto-
chrome c1 increased. The delay of photosynthetic growth is also
observed for R. sphaeroides mutants lacking subunit IV [9] and for al-
anine substitution at residues 100–103 of ISP [30].
It is rather surprising that after such a long lag time, these two fu-
sion mutants started to grow photosynthetically at a rate comparable
to that of the wild-type cells. Although, at present, we do not know
how the seemingly photosynthetically incompetent mutant strains
develop into photosynthetically competent phenotype, we do incline
to believe that this event is a consequence of adaptation rather than
mutation in the bc operon or elsewhere in the genome. Adaptation
was supported by re-growing the photosynthetically grown wild-
type and mutants c1-14Gly-IV-6His and c1-6Gly-IV-6His cells under
aerobic conditions and observing a lag of 24, 64 and 120 h in their re-
spective growth curves, when these cells were again grown under
photosynthetic conditions. If this event was a consequence of reverse
mutation somewhere in the genome of R. sphaeroides, one would ex-
pect that this mutation is heritable and the resulting mutant when
re-grew under photosynthetic conditions should behave like the
wild-type with a lag of 24 h. Adaptation was further substantiated
by ﬁnding the mutation-free fbcF,B,C,Q genes isolated from photosyn-
thetically grown mutants c1-6Gly-IV-6His and c1-14Gly-IV-6His. Also,
Western blotting analysis using anti-subunit IV and anti-c1 antibodies
detected no free c1 and subunit IV in chromatophore and puriﬁed
complexes isolated from the fused mutants.
One potential reason for the need of such long lag phase for the
fused mutants to start photosynthetic growth is to change the mem-
brane structure (or to modify the lipid environment of the mutant
complex) to allow electrons to be transferred from the reaction cen-
ter to the fused mutant complex. When adapted photosynthetically
grown mutants re-grew under aerobic conditions, the membrane
structures (or lipid environments) were reverted back to the original
one and thus the mutants needed a long lag phase again to start pho-
tosynthetic growth. Since the c1-6Gly-IV-6His mutant complex is
structurally less ﬂexible than the c1-14Gly-IV-6His mutant complex,
at least at the fused region, therefore it needs a longer lag phase to
change the membrane structure (or lipid environment) than that of
mutant c1-14Gly-IV-6His.3.3. Characterization of the c1-14Gly-IV-6His mutant complex
When chromatophores were prepared from adapted, photosyn-
thetically grown mutants c1-6Gly-IV-6His or c1-14Gly-IV-6His, the
speciﬁc cytochrome b contents in these two mutant chromatophores
were comparable to that in the wild-type chromatophore (0.8±
0.1 nmol cytochrome b/mg protein). Puriﬁcation of mutant bc1
complexes using DM solubilization followed by Ni-NTA afﬁnity
gel chromatography under the same conditions, however, generated
different results. The yield of puriﬁed c1-14Gly-IV-6His mutant was
comparable to that of wild-type (12%), whereas the yield of puriﬁed
c1-6Gly-IV-6His mutant complex was extremely low (b1%). The
yield was deﬁned as % of the total cytochrome bc1 complex (based
on cytochrome b or cytochrome c1 content) present in a given volume
of chromatophore recovered in the ﬁnal puriﬁed state. Since only very
little of bc1 complex from c1-6Gly-IV-6His mutant was able to bind to
the Ni-NTA column, the structures of cytochrome c1 and subunit IV in
this fusedmutant complexmay have been altered to the point that the
His-tag became less accessible. Therefore, this mutant was eliminated
from this study.The absorption spectra of cytochromes b and c1 in puriﬁed c1-
14Gly-IV-6His mutant complex (see Fig. 3B) were similar to those
in the wild-type complex (see Fig. 3A). The cytochrome b content in
the mutant complex (9.6±0.1 nmol/mg protein) was also compara-
ble to that in the wild-type complex (10.0±0.1 nmol/mg protein).
The ratio between cytochrome b and cytochrome c1 in this mutant
complex was around 1.4 (see Fig. 3, A and B), similar to that in the
wild-type complex. The iron–sulfur cluster contents in puriﬁed
wild-type and c1-14Gly-IV-6His mutant complexes were comparable,
judging by the EPR signal at gy=1.89 (see Fig. 3C).
Fig. 4A shows SDS-PAGE of the puriﬁed wild-type and c1-14Gly-
IV-6His mutant complexes. As expected, the wild-type complex
shows four major protein bands with apparent molecular masses of
43, 31, 23, and 14 kDa (see lane 2 of Fig. 4A) corresponding to cyto-
chrome b, cytochrome c1, Rieske iron–sulfur protein, and subunit IV.
The puriﬁed mutant complex, on the other hand, shows only three
major protein bands with apparent molecular masses of 46, 43 and
23 kDa, respectively (see lane 3 of Fig. 4A). Although the separation
between the two large proteins was not optimum due to their close
molecular weight, it is expected that the 43-kDa protein band is cyto-
chrome bwhile the 46 kDa band is the fused adduct of cytochrome c1
and subunit IV.
To further conﬁrm that the 46 kDa protein band observed in the
mutant complex is a c1–IV fusion protein, both the wild-type and mu-
tant complexes were subjected to Western blot analysis using anti-
bodies against R. sphaeroides cytochrome c1 (Fig. 4B) and antibodies
against R. sphaeroides subunit IV (Fig. 4C). In the wild-type complex,
antibodies against cytochrome c1 and subunit IV detected the cytochrome
c1 protein (Mw=31 kDa) and subunit IV protein (Mw=14 kDa) respec-
tively. In themutant complex, however, only a single band at amolecular
weight of 46 kDa was recognized. This result conﬁrmed that in the
c1-14Gly-IV-6His mutant complex subunit IV and cytochrome c1
are fused together as a protein with an apparent molecular weight
of 46 kDa.
When puriﬁed c1-14Gly-IV-6His mutant complex was subjected to
ubiquinol–cytochrome c reductase activity assay, it showed a speciﬁc
activity of 4.0±0.2 μmol cyt. c reduced per min per nmol cyt. b, which
is 60% higher than that of the wild-type complex (2.5±0.1 μmol cyt. c
reduced per min per nmol cyt. b). As the observed higher activity for
the mutant complex was a surprise, extra care was taken in puriﬁcation
steps. Speciﬁcally, we have carried out the puriﬁcation experiments of
wild-type and mutant proteins, side by side using the same detergent
andbuffers,multiple times. For each batch of the preparations, the activ-
ity was determined with the same assay mixture and substrate ﬁve
times, reducing the error in the average speciﬁc activity to 5%. The in-
creased activity observed in the c1-14Gly-IV-6His mutant complex is
most likely due to the presence of more subunit IV in the mutant com-
plex than that in thewild-type complex. In the c1-14Gly-IV-6Hismutant
complex, subunit IV is fused to cytochrome c1 and a 6-His tag is placed at
the C-terminal end of subunit IV, therefore no loss of subunit IV should
occur during the puriﬁcation process. Thus, a unit ratio between subunit
IV and cytochrome c1 should be present in the puriﬁedmutant complex.
In the wild-type complex, a 6-His tag is placed at the C-terminal end of
the cytochrome c1 subunit, and the amount of subunit IV associatedwith
cytochrome c1 depends on the binding afﬁnity of subunit IV to cyto-
chrome c1 under the detergent concentration used during puriﬁcation
process. Some loss of subunit IV is expected. In this case, a less than
unit ratio between subunit IV and cytochrome c1 would be present in
the wild-type complex.
As predicted, when the wild-type and mutant complexes were
subjected to an ELISA assay using antibodies against subunit IV, the
mutant complex had about 30±3% more subunit IV than the wild-
type complex. It should be noted that the absolute amounts of sub-
unit IV in the wild-type and mutant complexes cannot be accurately
determined based on the color intensities of antibody reacting to sub-
unit IV bands in Western blot simply because the blotting efﬁciencies
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Fig. 3. The absorption and EPR spectra of cytochromes b and c1 in the wild type and c1-14Gly-IV-6His mutant complexes. The difference absorption spectra of cytochrome b (solid
lines) and cytochrome c1 (dashed lines) in the wild-type (A) and c1-14Gly-IV-6His (B) mutant complexes. The difference spectra of cytochrome b were determined by measuring
the dithionite reduced minus the ascorbate reduced samples and the difference absorption spectra of cytochrome c1 were determined by measuring the ascorbate reduced minus
the ferricyanide oxidized samples. C. EPR spectra of the wild-type (black line) and c1-14Gly-IV-6His (gray line) mutant complexes. The experimental conditions were as described
in Section 2.
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difference in their molecular masses.
In order to ascertain that the activity increase observed in the c1-
14Gly-IV-6His mutant complex is indeed due to the presence of30 kDa
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Fig. 4. SDS-PAGE and Western blot analyses of puriﬁed wild type and c1-14Gly-IV-6His
mutant complexes. A. SDS-PAGE pattern. Lanes 1–3 were protein standards, wild-type
and mutant complexes, respectively. B. Western blot using antibody against R. sphaer-
oides cytochrome c1 as the primary antibody. Lanes 2 and 3 were the wild-type and
mutant complexes, respectively. C. Western blot using antibody against R. sphaeroides
subunit IV as the primary antibody. Lanes 2 and 3 were the wild-type and mutant com-
plexes, respectively.more subunit IV in the mutant complex, puriﬁed recombinant subunit
IV was added to the wild-type complex and electron transfer activity
was assayed. Maximum activity of 4.3±0.2 μmol c reduced per min
per nmol b was obtained when a molar excess of subunit IV was
added, indicating that this wild-type complex preparation was some-
what deﬁcient in subunit IV. However, we cannot use this result as a
basis to conclude that all the previously prepared wild-type com-
plexes with reported speciﬁc activities of less than 4.3±0.2 μmol c re-
duced per min per nmol bwere deﬁcient in subunit IV. This is because
the activity of this bacterial complex varies greatly by the detergent
(type and concentration) used in solubilization, puriﬁcation and
assay, and the ubiquinol derivative (Q0C10BrH2, Q0C10H2, or Q2H2)
used as substrate. The only way to determine whether or not a prep-
aration of the wild-type complex is deﬁcient in subunit IV is to add
subunit IV to the prepared complex and assay the activities of the
wild-type complex alone and subunit IV added wild-type complex
at the same time under identical conditions. An increase in activity in-
dicates a deﬁciency of subunit IV in the complex, no change in activity
indicates no deﬁciency of subunit IV in the complex.
Fig. 5 compares the superoxide production by the wild-type and
mutant c1-14Gly-IV-6His complexes measured with the chemilumi-
nescence method [25,26]. The MCLA-O2.− chemiluminescence in-
duced by the wild type bc1 complex reached its maximum peak
height (0.17 V) and then decreased. A maximum peak intensity of
0.11 V was induced by the c1-14Gly-IV-6His mutant complex, which
was about 30% less than that of the wild-type complex. The observa-
tion that the c1-14Gly-IV-6His mutant complex has a higher electron
transfer activity but a lower superoxide producing activity as com-
pared to the wild-type complex is consistent with our previous
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
Vo
lta
ge
 (V
)
Time (Sec)
0.0 0.5 1.0 1.5 2.0
Fig. 5. Superoxide generation by the wild-type and c1-14Gly-IV-6His mutant com-
plexes. The experimental conditions were as described in Section 2. The produced
chemiluminescence in voltage was monitored in 2 s. The black line represents the
wild-type complex and the gray line represents the mutant complex.
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Fig. 7. Differential scanning calorimetry of the wild-type and c1-14Gly-IV-His mutant
complexes. The curve with black line represents the wild-type complex and the gray
line represents the mutant complex.
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portional to the superoxide-generating activity in the bc1 complex.
The c1-14Gly-IV-His mutant complex is structurally more stable
than the wild-type enzyme, as shown by the fusion mutant complex's
higher tolerance to detergent treatment and its higher thermotropic
denaturation temperature as compared to the wild-type complex.
As shown in Fig. 6, the treatment of puriﬁed wild-type and c1-
14Gly-IV-6His mutant complexes with varying concentrations of
DM led to decreased activity with increasing concentrations of the de-
tergent. However, the extent of activity decrease, at a given concen-
tration of DM treatment, was less in the mutant complex than that
in the wild-type complex. At 0.013% of DM (130 μg/mL) treatment,
the wild-type protein (100 μg/mL) lost ~81% of its electron transfer
activity, whereas the mutant protein (104 μg/mL) lost only ~36%, in-
dicating that the c1-14Gly-IV-6His mutant complex is structurally
more stable than the wild-type protein. This was further veriﬁed by
a DSC experiment where the thermotropic properties of the puriﬁed
wild type and mutant proteins were analyzed and compared. Fig. 7
shows DSC thermograms of the wild-type and c1-14Gly-IV-6His mu-
tant complexes. When the wild type complex underwent thermode-
naturation, it showed a Tm of 45.3 °C and ΔH of 128.7 kcal/mol.10
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Fig. 6. Effect of DM concentration on the bc1 activities of the wild-type and c1-14Gly-IV-
His mutant complexes. The wild-type (ο) and mutant (x) complexes, 1 μM cytochrome
b, were treated with indicated concentrations of DM and incubated for 1 h on ice. Ali-
quots were then withdrawn for bc1 activity assays. The purities of wild type and mu-
tant complexes used were 10.0 and 9.6 nmol cytochrome b per mg protein,
respectively. The 100% activity was set as 4.86 μmol cyt.c reduced/min/nmol cyt.b.Under the same conditions, the c1-14Gly-IV-6His complex had a Tm
of 47.8 °C and ΔH of 187.7 kcal/mol. The increase in Tm of the mutant
complex indicates that this fusion mutant complex need higher tem-
perature to unfold the protein and is thermodynamically more stable
than the wild-type complex. Furthermore, when the complexes were
kept at room temperature for 20 h, the wild-type complex lost about
42% of its electron transfer activity, whereas the mutant complex lost
only about 14% of its activity (data not shown).
3.4. Crystallization and preliminary X-ray diffraction analysis
Crystals of the stigmatellin treated mutant c1-14Gly-IV-6His com-
plex (see Fig. 8) were obtained only when the Sr2+ ions which was
added during crystallization of the wild-type complex was replaced
with the K+ ions (~50 mM). Themutant crystals contained four protein
subunits as revealed by SDS-PAGE andWestern blots. The crystals were
ﬂash frozen in liquid propane andmaintained at a temperature of 100 K
during X-ray data collections at the Advanced Photon Source (APS) at
the Ser-CAT beamline 22. The diffraction pattern of the best crystal ex-
tended to 5.5 Å and displayed the symmetry of space group P42212.We
are in the process of optimizing crystallization conditions aiming at
obtaining crystals of higher quality. It is expected that a higher resolu-
tion structure of the 4-subunit cytochrome bc1 complex will be
obtained when a better crystal preparation is achieved.Fig. 8. Crystals of c1-14Gly-IV-6His mutant complex.
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The X-ray crystallography has emerged as a dominant technique for
structure determination of membrane protein complexes. The loss of
integral components or subunits during complex crystallization has
been observed, leading to incomplete structural information and de-
manding remedies for improvement in complex preparation and crys-
tallization procedure. In this work, we explore the genetic approach of
covalently linking the interested subunit to other more stable subunits
in a protein complex in order to mitigate the problem of subunit loss
during crystallization. The data presented here conﬁrms the usefulness
of this approach usingbacterial cytochrome bc1 complex as amodel sys-
tem. The key points that this paper deals with are: (i) the loss of subunit
IV in R. sphaeroides bc1 complex during crystallization can be prevented
by fusing the subunit IV gene with the gene of a core subunit, and the
structural constraint thus introduced can be alleviated by placing a
poly-glycine linker of proper length between these two fused subunits,
(ii) the mutant strain typically require a longer than expected adapta-
tion time, and (iii) the fusion protein displays better than expected
properties, which are required for the structure-function study of the
cytochrome bc1 complex.
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